Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC). J of Skin [Internet]. 2022 Nov. 16 [cited 2025 Apr. 19];6(6):s96. Available from: https://skin.dermsquared.com/skin/article/view/1855